5-HT2A Agonist Compounds for Anti-Inflammatory Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammatory disorders, such as those targeting TNF-α signaling, lack effective small molecule anti-inflammatory compounds, and existing serotonin receptor agonists have limitations in therapeutic applications.
Innovation Solution
Development of 2C compounds, including formulas (I), (II), and (III), and their pharmaceutically acceptable acid addition salts, which act as potent agonists of the serotonin 5-HT2A receptor, providing high anti-inflammatory potency without significant central nervous system effects, formulated into various pharmaceutical compositions for oral, intranasal, and pulmonary administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If small molecule anti-inflammatory compounds are developed to treat inflammatory disorders, then therapeutic effectiveness is improved, but selectivity between anti-inflammatory action and central nervous system effects deteriorates
Solution Approach 1:
The patent applies local quality by modifying specific molecular structures (2C compounds with particular R groups) to achieve selective action at peripheral serotonin receptors while avoiding central nervous system penetration. The structural modifications create localized properties that enable the compound to interact with peripheral 5-HT2A receptors in inflamed tissues without crossing the blood-brain barrier, thus providing anti-inflammatory effects without psychoactive side effects
Solution Approach 2:
The patent employs parameter changes by systematically varying molecular parameters (such as R group substitutions: isopropyl, tert-butyl, isobutyl) of the 2C compound core structure to optimize the balance between anti-inflammatory potency and CNS penetration. By adjusting these molecular parameters, the invention achieves compounds that maintain high affinity for peripheral serotonin receptors while reducing central nervous system effects through controlled modification of lipophilicity and molecular size
2Object-affected harmful factors
If precise dosing is used to minimize psychoactive side effects, then safety is improved, but dosing complexity increases
Solution Approach 1:
The patent applies self-service by designing the 2C compound molecular structure to inherently provide selective peripheral action without requiring complex dosing regimens. The structural features (specific R group configurations) enable the compound to self-select for peripheral receptor binding over central nervous system penetration, eliminating the need for complex dosing schedules or administration protocols to prevent psychoactive effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The 2C compounds effectively treat inflammatory disorders like asthma, chronic obstructive pulmonary disease, and other conditions with low circulating drug plasma levels, minimizing psychoactive side effects, and are administered in precise dosages to achieve therapeutic benefits.
Implementation Method 1
2C compounds, including formulas (I), (II), and (III), and their pharmaceutically acceptable acid addition salts, which act as potent agonists of the serotonin 5-HT2A receptor
Data Source
Figure 1A
Figure 1B
Figure 1B
AI summary
The invention features compounds and pharmaceutical compositions having anti-inflammatory properties. Also provided are methods of using the compounds or compositions of the invention for treating an inflammatory disorder in a subject in need thereof.